Impact of Iran’S Package of Essential Non-Communicable Disease (Irapen) on Cardiovascular Disease Risk Publisher



Karimi F¹ ; Darabi F² ; Ezzati F³ Show Affiliations
Source: Discover Social Science and Health Published:2025

Abstract

Objective: The purpose of this study was to evaluate the results of providing heart disease risk assessment services in order to determine the information needs for the necessary interventions in the comprehensive health service centers of Ardabil province. Methods: The present descriptive and analytical study was conducted in Ardabil University of Medical Sciences from March 2019 to the end of 2020, and used the data available in the registration system of the health network system. The sample size was determined based on the formula of 256 people. Based on the information from integrated health system (SIB), the values of the first screening variables and risk score were extracted. After that, these values were also recorded in the second screening. Results: Most of the patients were married, urban, and in the age group of 60–69. The highest history of risk factors in the target group was high blood pressure at 52% and diabetes mellitus (DM) at 49.2%, respectively, and alcohol consumption was the lowest at 3.2%. The paired t test shows, the difference in the patient’s cholesterol level, systolic blood pressure and diastolic blood pressure in the first screening compared to the second had statistical significance (p < 0.001). Conclusion: The results of the study showed that in Ardabil province, the implementation of the risk assessment program reduces heart disease risk by affecting cholesterol, systolic blood pressure, and diastolic blood pressure. This means that many premature deaths caused by heart disease can be prevented, by increasing people’s awareness and the efforts of healthcare providers in Iran. © The Author(s) 2025.